Concepedia

Julie C. Friedland

JC

9

Publications

1.5K

Citations

9

H-Index

2004

Active since

Affiliations

University of Pennsylvania(Current)

Synta Pharmaceuticals (United States)

Julie C. Friedland is an author at University of Pennsylvania specializing in medicine, tumor biology, and tumor microenvironment.

Top concepts

Publications per year

2004–2022

9

Publications

9

Mechanically Activated Integrin Switch Controls α <sub>5</sub> β <sub>1</sub> Function

Julie C. Friedland, Mark H. Lee, David Boettiger · Science · 2009 · 702 citations

, , +20

Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors

John F. Cryan, Olivia F. O’Leary, Sung‐Ha Jin et al. · Proceedings of the National Academy of Sciences · 2004 · 251 citations · Full text

Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

Jim Sang, Jaime Acquaviva, Julie C. Friedland et al. · Cancer Discovery · 2013 · 209 citations · Full text

Targeting KRAS-Mutant Non–Small Cell Lung Cancer with the Hsp90 Inhibitor Ganetespib

Jaime Acquaviva, Donald L. Smith, Jim Sang et al. · Molecular Cancer Therapeutics · 2012 · 98 citations

, , +15

α6β4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-κB-dependent resistance to apoptosis in 3D mammary acini

Julie C. Friedland, Johnathon N. Lakins, Marcelo G. Kazanietz et al. · Journal of Cell Science · 2007 · 88 citations

, , +22

Rows per page

1–5 of 9